High dose chemotherapy and autologous stem cell transplantation for metastatic breast cancer: is there a place?

被引：0
作者：
Stadtmauer, EA [1 ]
机构：
[1] Univ Penn, Ctr Canc, Bone Marrow & Stem Cell Transplant Program, Philadelphia, PA 19104 USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2003年 / 81卷
关键词：
high dose chemotherapy; metastatic breast cancer; stem cell transplant;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Seven comparative trials with over 2000 patients enrolled show no definitive evidence that high dose chemotherapy with stem cell support offers a survival advantage for metastatic breast cancer over conventional dose chemotherapy. Though numbers are low and small differences may exist particularly in subsets of patients, the duration of follow-up is adequate to make the likelihood of a late benefit low. High dose chemotherapy with stem cell transplantation does not have a place in the treatment of metastatic breast cancer outside of clinical trials.
引用
收藏
页码：S111 / S115
页数：5
相关论文
共 50 条
  • [21] High-dose chemotherapy consolidation with autologous stem cell rescue in metastatic breast cancer: a 10-year experience
    GF Laport
    G Grad
    DL Grinblatt
    JD Bitran
    SF Williams
    Bone Marrow Transplantation, 1998, 21 : 127 - 132
  • [22] High-dose chemotherapy consolidation with autologous stem cell rescue in metastatic breast cancer: a 10-year experience
    Laport, GF
    Grad, G
    Grinblatt, DL
    Bitran, JD
    Williams, SF
    BONE MARROW TRANSPLANTATION, 1998, 21 (02) : 127 - 132
  • [23] Critical issues on high-dose chemotherapy with autologous hematopoietic progenitor cell transplantation in breast cancer patients
    Martino, Massimo
    Bottini, Alberto
    Rosti, Giovanni
    Generali, Daniele
    Secondino, Simona
    Barni, Sandro
    Maisano, Roberto
    Lanza, Francesco
    Castagna, Luca
    Pedrazzoli, Paolo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (11) : 1505 - 1515
  • [24] Infectious complications from high-dose chemotherapy and autologous stem cell transplantation for metastatic germ cell tumors
    Jathavedam, Ashwin
    Feldman, Darren R.
    Ishill, Nicole
    Turkula, Stefan
    Patil, Sujata
    Bosl, George J.
    Motzer, Robert J.
    Weinstock, David M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (05) : 595 - 600
  • [25] Interleukin-2 and granulocyte-macrophage-colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer
    Cheng, Yee Chung
    Rondon, Gabriela
    Sanchez, Leah F.
    McMannis, John D.
    Couriel, Daniel R.
    de Lima, Marcos J.
    Hosing, Chitra
    Khouri, Issa F.
    Giralt, Sergio A.
    Champlin, Richard E.
    Ueno, Naoto T.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 90 (05) : 627 - 634
  • [26] Interleukin-2 and granulocyte–macrophage–colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer
    Yee Chung Cheng
    Gabriela Rondón
    Leah F. Sanchez
    John D. McMannis
    Daniel R. Couriel
    Marcos J. de Lima
    Chitra Hosing
    Issa F. Khouri
    Sergio A. Giralt
    Richard E. Champlin
    Naoto T. Ueno
    International Journal of Hematology, 2009, 90 : 627 - 634
  • [27] HER2 overexpression as a prognostic factor in metastatic breast cancer patients treated with high-dose chemotherapy and autologous stem cell support
    V Guarneri
    C Bengala
    C Orlandini
    A Gennari
    S Donati
    D Campani
    P Collecchi
    M Maur
    P F Conte
    Bone Marrow Transplantation, 2004, 34 : 413 - 417
  • [28] High-Dose Chemotherapy and Autologous Stem Cell Transplant
    Adra, Nabil
    Abonour, Rafat
    UROLOGIC CLINICS OF NORTH AMERICA, 2019, 46 (03) : 439 - +
  • [29] HER2 overexpression as a prognostic factor in metastatic breast cancer patients treated with high-dose chemotherapy and autologous stem cell support
    Guarneri, V
    Bengala, C
    Orlandini, C
    Gennari, A
    Donati, S
    Campani, D
    Collecchi, P
    Maur, M
    Conte, PF
    BONE MARROW TRANSPLANTATION, 2004, 34 (05) : 413 - 417
  • [30] Idiopathic pneumonia syndrome after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for high-risk breast cancer
    R Wong
    G Rondon
    R M Saliba
    V R Shannon
    S A Giralt
    R E Champlin
    N T Ueno
    Bone Marrow Transplantation, 2003, 31 : 1157 - 1163
12345